12:00 AM
 | 
Apr 20, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Prezista darunavir regulatory update

Health Canada approved an expanded label for once-daily Prezista darunavir from Johnson & Johnson to...

Read the full 62 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >